Interaction of Na, K-ATPase with chlorpromazine free radical and related compounds.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000528:radiation effects; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001692:Biological Transport; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology*; D002794:Choline / Q000378:metabolism; D002800:Cholinesterase Inhibitors; D003579:Cytochrome Reductases / Q000037:antagonists & inhibitors; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation; D005609:Free Radicals; D006321:Heart / Q000187:drug effects; D007700:Kinetics; D008861:Microsomes / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology*; D011830:Radiation Effects; D051381:Rats; D012964:Sodium / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013574:Synaptosomes / Q000201:enzymology; D014466:Ultraviolet Rays
D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D005609:Free Radicals; D012964:Sodium; D003579:Cytochrome Reductases; D000251:Adenosine Triphosphatases; D002794:Choline; D011188:Potassium; D002118:Calcium; D002746:Chlorpromazine